Plains GP Holdings’ strategic JV with Oryx to boost volumes, Stifel Buy rating By Investing.com

On Monday, Stifel has raised its price target on Plains GP Holdings, L.P (NASDAQ:) to $23.00, up from the previous target of $22.00, while reiterating a Buy rating on the stock. The firm cited the company’s strong positioning as a major transporter of crude from the Permian Basin, expecting it to benefit from increased volumes in the coming years.

The analyst noted that Plains GP Holdings’ joint venture with Oryx is anticipated to secure additional barrels for the company’s long haul pipelines in the long term. This strategic partnership is poised to enhance the company’s ability to handle increased transportation demands.

Plains GP Holdings has shown a notable improvement in its financial profile over recent years, which includes a significant distribution increase of approximately 20%. This is seen as a reflection of the company’s strengthened financial health and commitment to rewarding its stakeholders.

The company’s prospects are further bolstered by expectations of substantial free cash flow generation in the future. According to Stifel, this financial capability is likely to support Plains in delivering increased capital returns to its stakeholders.

Plains GP Holdings’ strategic initiatives and financial performance have positioned it favorably in the eyes of Stifel, which is reflected in the upgraded price target and sustained Buy rating. The company’s focus on key transport routes and partnerships, improved financials, and potential for capital returns are central to Stifel’s positive outlook.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.